CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-09 | SHOVLIN ROBERT J. President, Clinical Services | Sale | −180,000 | $17.05 | $3.1M | 159,884 |
| 2018-11-09 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion · Stock Option (Right to Buy) | −300,000 | 0 | ||
| 2018-11-09 | GENERAL ELECTRIC CO 10% owner | Sale | −4,164,855 | $16.75 | $69.8M | 10,835,145 |
| 2018-10-22 | BRODIE STEVEN G. VP - Pharma Operations | Exercise or conversion | +13,334 | $3.45 | $46K | 45,953 |
| 2018-10-22 | BRODIE STEVEN G. VP - Pharma Operations | Exercise or conversion · Stock Option (Right to Buy) | −13,334 | 0 | ||
| 2018-08-03 | VAN OORT DOUGLAS M Chairman and CEO | Shares withheld for taxes | −21,904 | 2,008,123 | ||
| 2018-08-03 | VAN OORT DOUGLAS M Chairman and CEO | Grant or award | +197,042 | 2,030,027 | ||
| 2018-08-01 | VAN OORT DOUGLAS M Chairman and CEO | Grant or award | +46,429 | 2,054,552 | ||
| 2018-08-01 | JONES STEVEN C Executive Vice President | Sale | −119,948 | $14.00 | $1.7M | 2,300,000 |
| 2018-07-31 | JONES STEVEN C Executive Vice President | Sale | −38,952 | $14.00 | $545K | 2,419,948 |
| 2018-07-30 | JONES STEVEN C Executive Vice President | Sale | −3,500 | $14.00 | $49K | 48,657 |
| 2018-07-30 | JONES STEVEN C Executive Vice President | Sale | −41,100 | $14.01 | $576K | 2,458,900 |
| 2018-06-29 | SHOVLIN ROBERT J. President, Clinical Services | Sale | −12,941 | $13.12 | $170K | 39,884 |
| 2018-06-25 | GENERAL ELECTRIC CO 10% owner | Other disposition · Series A Convertible Preferred Stock | −6,864,000 | $7.30 | $50.1M | 0 |
| 2018-06-22 | JONES STEVEN C Executive Vice President | Sale | −89,688 | $14.04 | $1.3M | 2,500,000 |
| 2018-06-19 | JONES STEVEN C Executive Vice President | Sale | −158,312 | $13.32 | $2.1M | 2,589,688 |
| 2018-06-15 | JONES STEVEN C Executive Vice President | Sale | −2,000 | $13.25 | $27K | 2,748,000 |
| 2018-06-01 | Johnson Kevin C Director | Grant or award | +15,564 | 143,873 | ||
| 2018-06-01 | Johnson Kevin C Director | Grant or award · Common Stock | +3,017 | 3,017 | ||
| 2018-06-01 | TETRAULT LYNN A. Director | Grant or award | +15,564 | 37,346 |
Page 44 of 51 · 1,005 trades